Accordingly, this study was conducted to assess the application value of serum TK1, PCDGF, CYFRA21-1, NSE, and CEA plus enhanced CT scan in the diagnosis of NSCLC and chemotherapy monitoring. The gene discussed is CEACAM5; the disease is non-small cell lung carcinoma.